When it comes to looking good, the world isn’t hesitant to spend money; simply notice the many ads for hair care and skin care products that permeate every form of media, observes Mark Skousen and Jim Wood, co-editors of Fast Money Alert.
The willingness for people to spend money on cosmetic goods, and even cosmetic medical procedures, means that there are many companies out there that will benefit mightily from that trend.
More from Mark Skousen: Assured Guaranty: A Book Value Bargain?
Enter the newest company doing just that — InMode Ltd. (INMD). Indeed, the fast money investing crowd loves this beauty. InMode is an Israeli company that is the provider of minimally invasive surgical aesthetic and medical treatment solutions in the United States.
Its products and solutions are designed to address three energy-based treatment categories, including face and body contouring, medical aesthetics and women’s health.
The technologies offered by the company include such brands as BodyTite, Contoura, EmbraceRF, Optimas and Votiva among others. These various brands are sold to medical offices and clinics that specialize in cosmetic skin care, weight reduction, cellulite removal, etc.
The key component of the equipment made by InMode is its radio frequency energy delivery technology, as well as other leading-edge technologies.
InMode only went public earlier this year (August 8). And unlike a lot of companies that go public, INMD actually already has stellar earnings growth.
In fact, the company is in the top 1% of all publicly traded stocks in the S&P 500 in terms of earnings per share growth over the past several years. Over the past three years, InMode has seen earnings per share growth at an average annual rate of 328%!
On November 5, the company reported earnings per share (EPS) of 42 cents, well above the consensus estimate of 29 cents. Revenue for the quarter also impressed, up 57.4% compared to the same quarter a year ago. This is the kind of stock the fast money was made for.
More From MoneyShow.com: